NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Acorda Therapeutics (ACOR) downgraded at Leerink from Outperform to Market Perform. Valuation call, as potential risks lay ahead.
American Eagle (AEO) upgraded at Wells from Market Perform to Outperform. Estimates also raised, to reflect the company's comp sales momentum.
Baker Hughes (BHI) reinstated at BofA/Merrill. BHI coverage reinstated with a Buy rating and $61 price target. HBI has above average exposure to higher growth, early cycle product service lines.Cameron International (CAM) reinstated at BofA/Merrill. CAM coverage reinstated with a Buy rating and $56 price target. Upside from integration of NATCO acquisition, Bank of America/Merrill Lynch said. Core Labs (CLB) initiated at BofA/Merrill. CLB coverage initiated with a Buy rating and $136 price target. Buy based on continuation of share buybacks, valuation, and earnings acceleration. Citrix Systems (CTXS) rated new Neutral at UBS. Coverage of CTXS was started with a Neutral rating. $47 price target. Stock is already pricing in increased IT spending. Deere (DE) upgraded at JP Morgan from Neutral to Overweight. $65 price target. Seeing signs of a recovery in multiple areas of equipment. Deere (DE) estimates, target increased at UBS. Shares of DE now seen reaching $61. Estimates also raised, because of higher expected agriculture demand. Neutral rating. Dril-Quip (DRQ) initiated at BofA/Merrill. DRQ coverage initiated with a Buy rating and $68 price target. Recent capacity expansion is driving revenue growth. FMC Technologies (FTI) reinstated at BofA/Merrill with an Underperform rating and $65 price target. Not many growth catalysts and poor valuation, Bank of America/Merrill Lynch said.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV